These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. [Effects of cardiovascular risk factors on hemorheologic parameters in cerebrovascular patients]. Szapáry L; Szóts M; Horváth B; Márton Z; Alexy T; Késmárky G; Juricskay I; Nagy F; Gaál V; Pálfi A; Koltai K; Tóth K Orv Hetil; 2003 Jun; 144(22):1085-90. PubMed ID: 12847818 [TBL] [Abstract][Full Text] [Related]
5. Hemorheological changes in children with polygenic hypercholesterolemia. Vayá A; Martínez M; Dalmau J; Aznar J Clin Hemorheol Microcirc; 1998 Nov; 19(3):259-62. PubMed ID: 9874362 [TBL] [Abstract][Full Text] [Related]
6. Investigation of hemorheological parameters in periodontal diseases. Seringec N; Guncu G; Arihan O; Avcu N; Dikmenoglu N Clin Hemorheol Microcirc; 2015; 61(1):47-58. PubMed ID: 25261434 [TBL] [Abstract][Full Text] [Related]
7. Do hemorheological alterations play any role in the development of thrombotic events in Behçet's disease? Vayá A; Ricart J; Todolí J; Micó L; Contreras T; Aznar J Clin Hemorheol Microcirc; 2004; 30(3-4):411-4. PubMed ID: 15258375 [TBL] [Abstract][Full Text] [Related]
8. [Hemorheologic factors in hypertensive and diabetic retinopathy]. Vékási J; Márton Z; Késmárky G; Cser A; Russai R; Kovács B Orv Hetil; 2001 May; 142(20):1045-8. PubMed ID: 11407065 [TBL] [Abstract][Full Text] [Related]
9. Rheological blood behavior is not only influenced by cardiovascular risk factors but also by aging itself. Research into 927 healthy Spanish Mediterranean subjects. Vayá A; Alis R; Romagnoli M; Pérez R; Bautista D; Alonso R; Laiz B Clin Hemorheol Microcirc; 2013 Jan; 54(3):287-96. PubMed ID: 23686090 [TBL] [Abstract][Full Text] [Related]
10. Blood fluidity, fibrinogen, and cardiovascular risk factors of occlusive arterial disease: results of the Aachen study. Koscielny J; Jung EM; Mrowietz C; Kiesewetter H; Latza R Clin Hemorheol Microcirc; 2004; 31(3):185-95. PubMed ID: 15322324 [TBL] [Abstract][Full Text] [Related]
11. Blood rheology and fibrinogen in children with familial hypercholesterolaemia. Jay RH; McCarthy SN; Rampling MW; Betteridge DJ Atherosclerosis; 1991 Nov; 91(1-2):117-21. PubMed ID: 1811547 [TBL] [Abstract][Full Text] [Related]
12. Hemorheological alterations in mild essential hypertension. Vayá A; Martínez M; Garcia J; Labios M; Aznar J Thromb Res; 1992 May; 66(2-3):223-9. PubMed ID: 1412193 [TBL] [Abstract][Full Text] [Related]
13. Hemorrheologic abnormalities in defined primary dyslipoproteinemias with both high and low atherosclerotic risks. Otto C; Ritter MM; Richter WO; Minkenberg R; Schwandt P Metabolism; 2001 Feb; 50(2):166-70. PubMed ID: 11229424 [TBL] [Abstract][Full Text] [Related]
14. Hemorheological alterations in patients with chronic renal failure. Effect of hemodialysis. Martínez M; Vayá A; Alvariño J; Barberá JL; Ramos D; López A; Aznar J Clin Hemorheol Microcirc; 1999; 21(1):1-6. PubMed ID: 10517483 [TBL] [Abstract][Full Text] [Related]
15. [New markers of atherogenic risk: hemorrheological profile in children and adolescents with familial hypercholesterolemia]. Dalmau Serra J; Vayá Montaña A; Martínez Silvestre M; Blesa Baviera LC; Aznar Lucea J An Esp Pediatr; 1996 Oct; 45(4):393-7. PubMed ID: 9005727 [TBL] [Abstract][Full Text] [Related]
16. Hemorheological and hemodynamic parameters in patients with essential hypertension and their modification by alpha-1 inhibitor drug treatment. Toth K; Kesmarky G; Vekasi J; Nemes J; Czopf L; Kapronczay P; Halmosi R; Papp E; Juricskay I Clin Hemorheol Microcirc; 1999; 21(3-4):209-16. PubMed ID: 10711745 [TBL] [Abstract][Full Text] [Related]